North Capital, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 2065938 SALT LAKE CITY, UT

Position in GILD

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$262,281

-$27,051 QoQ

Shares Held

2,076

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.59%

of 13F equity value

Holder Rank

#1,754

of 2,266 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

North Capital, Inc. holds $1,795,940 across 5 Drug Manufacturers - General names. GILD ranks #5 (14.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	1,920	$483,148
2	JNJ	Johnson & Johnson	1,554	$394,669
3	MRK	Merck & Co., Inc.	2,957	$379,974
4	LLY	ELI LILLY & Co	230	$275,868
5	GILD	Gilead Sciences, Inc. This page	2,076	$262,281

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$262,281	2,076	0.0%	Shares	Sole	2026-07-14
2026-03-31	$289,332	2,076	-0.1%	Shares	Sole	2026-04-30
2025-12-31	$255,176	2,079	-0.0%	Shares	Sole	2026-02-18
2025-09-30	$230,880	2,080	+2.5%	Shares	Sole	2025-10-09
2025-06-30	$224,955	2,029	-7.8%	Shares	Sole	2025-08-06
2025-03-31	$246,622	2,201	—	Shares	Sole	2025-04-28
No filing history on record for this holder in this stock.